Health Care and Technology are expected to see operating EPS growth accelerate in Q3. Most cyclical Value sectors are not expected to see meaningful growth until 2021 when comps get easier. Additional fiscal stimulus looks priced in for many cyclical Value sectors.
Complete the form and a member of our team will send you a copy of this publication.
While you wait, explore additional NDR research and solutions.
Institutional Investors
Custom Research
Wealth Managers
Stock Selection
ETF Selection
Please note that you are using an unsupported browser. While the site will continue to function, you might experience sub-optimal behavior until you upgrade. Please update your browser to a later version for a better experience.